Ginkgo Biomedical Research Institute, Carna Biosciences, CrystalGenomics To Collaborate In New Cancer Drug Development

... Tokyo, (JCN) - In a partnership initiated by Summit Pharmaceuticals International, Ginkgo Biomedical Research Institute, Carna Biosciences, and CrystalGenomics jointly announced on March 14 that they have agreed to collaborate in the development of an anti-cancer agent. Under this partnership, the three companies will strive to develop an agent that inhibits the activity of Cdc7-ASK kinase, which plays a role in chromosomal DNA replication... click link for more info. ...